WSW, NY, 19th March 2026, FinanceWire … Read More
SPY
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
WSW, NY, 19th March 2026, FinanceWire … Read More
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
WSW, NY, 18th March 2026, FinanceWire … Read More
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
WSW, NY, 16th March 2026, FinanceWire … Read More
Duke Robotics Could Be One of the Underdog Companies Emerging From Israel’s Drone Tech Boom (OTCQB: DUKRD)
WSW, NY, 12th March 2026, FinanceWire … Read More
Duke Robotics May Be the Most Overlooked Drone Player in the Israeli Defense Boom (OTCQB: DUKR)
WSW, NY, 5th March 2026, FinanceWire … Read More
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
WSW, NY, 5th March 2026, FinanceWire … Read More
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
WSW, NY, 2nd March 2026, FinanceWire … Read More
Nasus Pharma Is Targeting a Validated Market With a Potentially Superior Intranasal Delivery Approach
WSW, NY, 19th February 2026, FinanceWire … Read More
Money Expo Mexico 2026 Starts with Historic Footfall in Latin America
Mexico, Mexico, 19th February 2026, FinanceWire … Read More